Pictet Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$409K Buy
88,480
+20
+0% +$99 ﹤0.01% 1630
2026
Q1
$410K Buy
88,460
+9,843
+13% +$51.3K ﹤0.01% 1577
2025
Q4
$393K Hold
78,617
﹤0.01% 1564
2025
Q3
$399K Hold
78,617
﹤0.01% 1508
2025
Q2
$339K Sell
78,617
-37,357
-32% -$185K ﹤0.01% 1570
2025
Q1
$699K Sell
115,974
-56,990
-33% -$288K ﹤0.01% 1211
2024
Q4
$683K Sell
172,964
-7,653
-4% -$34.3K ﹤0.01% 1246
2024
Q3
$1.06M Sell
180,617
-341
-0.2% -$1.68K ﹤0.01% 1020
2024
Q2
$780K Buy
180,958
+18,756
+12% +$89.9K ﹤0.01% 1091
2024
Q1
$762K Buy
162,202
+5,880
+4% +$22.5K ﹤0.01% 1128
2023
Q4
$768K Sell
156,322
-765
-0.5% -$3.75K ﹤0.01% 1082
2023
Q3
$856K Buy
+157,087
New +$1.26M ﹤0.01% 1013

Other funds holding MPT

Pictet Asset Management's MPT Position: Q2 2026 in Review

Pictet Asset Management increased its Medical Properties Trust (MPT) stake by 0.02% in Q2 2026, buying an estimated $99 and bringing the position to 88,480 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Pictet Asset Management first reported a position in MPT in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.06M in Q3 2024. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Pictet Asset Management held 88,480 shares of Medical Properties Trust worth $409K as of Q2 2026.
  • Pictet Asset Management bought 20 Medical Properties Trust shares in Q2 2026, an estimated $99.
  • Medical Properties Trust made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1630 holding.
  • Pictet Asset Management first reported a position in Medical Properties Trust in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Medical Properties Trust position peaked at $1.06M in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.